Fleury S.A. (BVMF:FLRY3)

Market Cap	6.89B
Revenue (ttm)	7.80B
Net Income (ttm)	627.50M
Shares Out	544.28M
EPS (ttm)	1.15
PE Ratio	10.97
Forward PE	9.74
Dividend	1.02 (8.05%)
Ex-Dividend Date	Mar 7, 2025

Volume	183,600
Average Volume	2,969,255
Open	12.65
Previous Close	12.65
Day's Range	12.61 - 12.82
52-Week Range	10.65 - 16.87
Beta	0.32
RSI	54.29
Earnings Date	May 8, 2025

About Fleury

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging se...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1926
• Employees: 27,500
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: FLRY3

Financial Performance

In 2024, Fleury's revenue was 7.68 billion, an increase of 18.76% compared to the previous year's 6.47 billion. Earnings were 616.17 million, an increase of 45.41%.